Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Molecubes

Request full access

Preclinical in-vivo imaging systems

Ghent, BelgiumFounded 2015Biotech & Life Sciences

About Molecubes

Molecubes, founded in 2015 as a spin-off from Ghent University-iMinds in Belgium, develops and manufactures modular benchtop preclinical imaging systems. The company was established by Professor Dr. Roel Van Holen, along with co-founders Pieter Mollet, Bert Vandeghinste, and Ewout Vansteenkiste, based on research to make complex molecular imaging technology more accessible. In January 2016, the company secured €1.9 million in seed funding to launch its initial products.

The company's core business is providing compact and user-friendly in-vivo imaging solutions for life science research. Its primary clients include academic and government research laboratories, pharmaceutical and biotechnology companies, and contract research organizations (CROs). The business model centers on the sale of its hardware, the 'CUBES', which are designed for high-performance imaging while maintaining a small footprint suitable for any lab bench. In November 2021, Molecubes was acquired by Bruker Corporation, a move intended to strengthen Bruker's preclinical imaging portfolio and expand the global reach of the CUBES technology. Molecubes continues to operate as an agile team within Bruker's BioSpin Preclinical Imaging division.

Molecubes offers three main products, each a separate benchtop imager that can be used as a standalone unit or in modular combination: the β-CUBE (a high-sensitivity micro-PET scanner), the γ-CUBE (a high-resolution micro-SPECT scanner), and the X-CUBE (a high-throughput, low-dose micro-CT scanner). These systems are designed for whole-body imaging of mice and rats, supporting research in fields like oncology, neurology, and cardiology. A key feature is their modularity, allowing researchers to perform PET/CT, SPECT/CT, or PET/SPECT/CT studies and enabling multiple users to work simultaneously. The systems are supported by intuitive, wireless software that simplifies workflows and makes advanced 3D imaging accessible to a broader range of researchers.

Source: Dealroom company data

At a glance

Status
Acquired
Employees
16
Open positions
None listed
Dealroom signal
66.6/100
Industry
Health
Sub-industry
BioTechnology
Sector
Intellectual Property, Analytics
Technology
Artificial Intelligence, Hardware, 3D Technology, Big Data, Deep Tech, Computer Vision
Business model
Manufacturing, SaaS
Client focus
B2B, B2C

Funding history

3 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
ACQUISITION✓Exit Nov 2021 $0 — Bruker ↗
SEED✓Equity / VC Jan 2016 $2.2M $8.8M Undisclosed ↗
Showing the latest 2 of 3 recorded eventsBook a demo for the full funding history →

Financials

Revenue, earnings and profit over time

Revenue, earnings and other financial measures where available. Years marked “E” are estimates.

YearEBITDAMarginProfitMargin
2026 — —
2025 — —
2024 — —
2023 — —
2022 — —
2021 — —
2020 — —
Company filings, research estimates and Dealroom dataBook a demo for the full financial model →

Growth signals

Molecubes website traffic

Latest recorded traffic for Molecubes is 2.4K monthly website visits, up 3900% over the last three months. Molecubes's team declined 11.1% over the past year.

Latest monthly visits2.4K 3-month web change+3900% 1-year team growth-11.1%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Molecubes in the Ghent ecosystem

Live from Dealroom

The Molecubes office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

7 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Other known investors7 additional known investors

  • Bruker
  • Ghent University
  • imec
  • imec.istart
  • imec.istart future fund
  • Qbic Fund
  • Walter Mastelinck
Team profiled 10 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 6 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

See Molecubes’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.